EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 47 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,750 | -93.9% | 1,178 | -91.8% | 0.00% | – |
| Q2 2023 | $110,717 | +2208.5% | 14,286 | +1886.9% | 0.00% | – |
| Q1 2023 | $4,796 | -41.9% | 719 | -22.1% | 0.00% | – |
| Q4 2022 | $8,252 | -17.5% | 923 | -13.3% | 0.00% | – |
| Q3 2022 | $10,000 | -58.3% | 1,064 | -64.7% | 0.00% | – |
| Q2 2022 | $24,000 | 0.0% | 3,013 | +22.9% | 0.00% | – |
| Q1 2022 | $24,000 | -86.1% | 2,451 | -78.4% | 0.00% | – |
| Q4 2021 | $173,000 | +592.0% | 11,336 | +657.2% | 0.00% | – |
| Q3 2021 | $25,000 | +92.3% | 1,497 | +155.0% | 0.00% | – |
| Q2 2021 | $13,000 | – | 587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |